Ravi V. Bellamkonda | |
---|---|
Born | 1968 (age 55–56) India |
Alma mater | |
Scientific career | |
Fields | Biomedical engineering, neural interfaces, human nervous system |
Institutions |
Ravi V. Bellamkonda (born 1968) is an Indian-American [1] biomedical engineer and academic administrator. Since 2021, he has served as Provost and Executive Vice President for Academic Affairs at Emory University in Atlanta, Georgia. [2] Bellamkonda was previously Vinik Dean of the Pratt School of Engineering at Duke University. [3] Pending approval by the Board of Trustees, he will serve as Provost and Executive Vice President for Academic Affairs at The Ohio State University in Columbus, Ohio, effective January 14, 2025. [4]
Bellamkonda's research was the subject of a BBC science report, "Cancer: 'Tumor Monorail' Can Lead Cancers to Their Doom" [5] He was also the subject of a feature profile in the Britain-based international journal, The Engineer . [6]
Bellamkonda served president of the American Institute of Medical and Biological Engineering (AIMBE) for the 2014-2016 term. [7] He has served as a member of the board for the Biomedical Engineering Society (BMES), and is on the editorial board for several scientific journals. He advises several biomedical engineering-related departments and programs nationally as a member of their external advisory boards.
Bellamkonda earned his Bachelor of Engineering degree in Biomedical Engineering at Osmania University in May 1989. He completed his Ph.D. in Medical Science and Biomaterials from Brown University in June 1994. [1] From 1994 to 1995, Bellamkonda was a Markey Post-Doctoral Research Fellow in the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology with Jerry Schneider and Sonal Jhaveri.
In 1995, he went on to become the Elmer L. Lindseth assistant professor at Case Western Reserve University in Cleveland, Ohio then advanced to associate professor in 2001.
In 2003, Bellamkonda joined Georgia Tech as an associate professor of biomedical engineering, and in 2005, he was promoted to professor in the Wallace H. Coulter Department of Biomedical Engineering, a joint department created by Emory's School of Medicine and the Georgia Tech College of Engineering.
From 2006 to 2013, he was the Carol Ann and David D. Flanagan Chair in Biomedical Engineering at Georgia Tech. [8] the Carol Ann and David D. Flanagan Chair in Biomedical Engineering [9] and Georgia Cancer Coalition Distinguished Scholar [10]
In 2008, he was named deputy director of research at the Georgia Tech/Emory Center for the Engineering of Living Tissues (GTEC), an NSF funded engineering research center. [11] Afterwards, in 2010, he was named associate vice president for research at the Georgia Institute of Technology, a position he held until 2013. [11]
In 2013, Bellamkonda was named the department chair of the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. [12] On August 1, 2016, he became Vinik Dean of the Pratt School of Engineering at Duke University. [13]
It was reported he will become Provost and Executive Vice President for Academic Affairs at Emory University on July 1, 2021, where he will have faculty appointments in the Department of Biology and the Wallace H. Coulter Department of Biomedical Engineering. [14]
Bellamkonda's primary area of research is the application of biomaterials to the human nervous system, including spinal nerve repair, neural interfaces, and brain tumor therapy. [15]
Biomedical engineering (BME) or medical engineering is the application of engineering principles and design concepts to medicine and biology for healthcare applications. BME is also traditionally logical sciences to advance health care treatment, including diagnosis, monitoring, and therapy. Also included under the scope of a biomedical engineer is the management of current medical equipment in hospitals while adhering to relevant industry standards. This involves procurement, routine testing, preventive maintenance, and making equipment recommendations, a role also known as a Biomedical Equipment Technician (BMET) or as a clinical engineer.
The Wallace H. Coulter Department of Biomedical Engineering is a department in the Emory University School of Medicine, Georgia Institute of Technology's College of Engineering, and Peking University College of Engineering dedicated to the study of and research in biomedical engineering, and is named after the pioneering engineer and Georgia Tech alumnus Wallace H. Coulter. The graduate program has consistently ranked 2nd in USNWR rankings, while the undergraduate program ranks 1st in USNWR rankings.
Dean Ho is a Provost's Chair Professor in the Departments of Biomedical Engineering and Pharmacology, Director of the N.1 Institute for Health, and Head of the Department of Biomedical Engineering at the National University of Singapore. He was previously a professor at UCLA, and associate professor in the Departments of Biomedical Engineering and Mechanical Engineering in the Robert R. McCormick School of Engineering and Applied Science, and Full Member of the Robert H. Lurie Comprehensive Cancer Center at the Feinberg School of Medicine of Northwestern University, Illinois, United States.
Anthony "Tony" Guiseppi-Elie is a Trinidad-born, American scientist, engineer, entrepreneur, and avid Wikipedia editor. He is the President and Sr. Fellow of the American International Institute of Medical Sciences, Engineering and Innovation and the President and Scientific director of ABTECH Scientific, Inc. He is noted for his research and commercial development of biologically inspired and chemically responsive electroconductive hydrogels. Guiseppi-Elie is the Founding Editor-in-Chief of the transdisciplinary journal Bioengineering.
The American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organization founded in 1991, and headquartered in Washington, D.C. It represents 50,000 medical and biomedical engineers, and academic institutions, private industry, and professional engineering societies.
Stanislav (Stas) Emelianov is a former professor of biomedical engineering at University of Texas at Austin. He is also the founder of Ultrasound Imaging and Therapeutics Laboratory. Since August 2015, he moved to Georgia Institute of Technology, where he has been appointed as the Joseph M. Pettit Chair in Microelectronics and as a Georgia Research Alliance Eminent Scholar. He is based in the Georgia Tech School of Electrical and Computer Engineering with a joint appointment in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.
George Alexander Truskey is an American biomedical engineer noted for his research on transport phenomena in biological systems, cardiovascular tissue engineering, and cell adhesion to natural and synthetic surfaces.
Akhilesh K. Gaharwar is an Indian academic and a professor in the Department of Biomedical Engineering at Texas A&M University.
Omolola (Lola) Eniola-Adefeso is a Nigerian-American chemical engineer and incoming Dean of the College of Engineering at the University of Illinois Chicago.
Jonathan S. Lewin is an American neuroradiologist specializing in medical imaging research with an emphasis on the investigation, development, and translation of new magnetic resonance imaging (MRI) techniques. He is the former executive vice president for health affairs (EVPHA) and executive director of the Woodruff Health Sciences Center for Emory University, and former President, CEO, and chairman of the board of Emory Healthcare. He currently serves as professor of radiology, biomedical engineering, and neurosurgery in the Emory School of Medicine and as professor of health policy and management in the Rollins School of Public Health.
Gilda A. Barabino is the president of the Olin College of Engineering, where she is also a professor of biomedical and chemical engineering. Previously, she served as the dean of The Grove School of Engineering at the City College of New York, and as a professor in the Departments of Biomedical Engineering and Chemical Engineering and the CUNY School of Medicine. On March 4, 2021, she became the President-Elect of the American Association for the Advancement of Science.
Debra Auguste is an American chemical engineer and professor at Northeastern University in the department of chemical engineering. Auguste is dedicated to developing treatments for triple negative breast cancer, one of the most aggressive and fatal cancers that disproportionately affects African American women. Her lab characterizes biomarkers of triple negative breast cancer and develops novel biocompatible therapeutic technologies to target and destroy metastatic cancer cells. Auguste received the 2012 Presidential Early Career Award for Scientists and Engineers and in 2010 was named in the 50 Most Influential African-Americans in Technology. In 2020, Auguste became an Elected Fellow of the American Institute for Medical and Biological Engineering.
Manu Omar Platt is an American biomedical engineer serving as the director of the NIH Biomedical Engineering Technology Acceleration (BETA) center. He also serves as NIBIB Associate Director for Scientific Diversity, Equity and Inclusion.
Jennifer L. West is an American bioengineer. She is the current Dean of Engineering and Applied Science at the University of Virginia. She was the Fitzpatrick University Professor of Biomedical Engineering at Duke University from 2012-2021. In 2000, West cofounded Nanospectra Biosciences in Houston to develop a cancer therapy based on gold nanoparticles that destroy tumor cells and has been listed by MIT Technology Review as one of the 100 most innovative young scientists and engineers world wide.
Chenzhong Li is a Chinese-born Canadian & American biomedical engineer, chemist, inventor, professor, and journal editor. Li is the co-Editor-in-Chief of the journal Biosensors and Bioelectronics (Elsevier) and the associate editors of journals RESEARCH (AAAS) and Biosensors (MDPI).
Stuart L. Cooper is an American engineer. As a Full Professor and Chair of Ohio State University's Department of Chemical and Biomolecular Engineering, Cooper was elected to the National Academy of Engineering in 2011.
Cynthia "Cindy" Reinhart-King is an American biomedical engineer and Department Chair of Bioengineering at Rice University. Her research considers cell motility and adhesion. She serves as president of the Biomedical Engineering Society.
Claudia Fischbach is a German bioengineer who serves as the James M. and Marsha McCormick Director of Biomedical Engineering and the Stanley Bryer 1946 Professor of Biomedical Engineering at Cornell University. She is Director of the Cornell Physical Sciences Oncology Center on the Physics of Cancer Metabolism.
May Dongmei Wang is a Chinese-American biomedical engineer whose research involves biomedical big data analytics, the interpretation and application of big data in medicine and biology, as generated from microarrays and quantum dots. She is a professor of biomedical engineering and Wallace H. Coulter Distinguished Faculty Fellow in the Wallace H. Coulter Department of Biomedical Engineering, a joint program of Georgia Tech, Emory University, and Peking University.
Ankur Singh is an Indian-American biomedical engineer and scientist whose research focuses on engineering immune system. He is a Carl Ring Family Endowed Professor at Georgia Institute of Technology in the George W. Woodruff School of Mechanical Engineering and Wallace H. Coulter Department of Biomedical Engineering. He serves as the Director of the Center for Immunoengineering at Georgia Tech.